Editorial Comment

There is no standard of care for biochemical relapse after definitive therapy of prostate cancer. When confronted with treatment options, there are 2 extremes in the patient response, including, “Start ADT to get PSA down under any circumstance” and “Defer ADT for as long as possible.” The former reaction occurs despite education about the long natural history of biochemical relapse without ADT or disease characteristics that support a longer time to metastatic disease, such as long er PSA DT or a Gleason score less than 8.
Source: The Journal of Urology - Category: Urology & Nephrology Authors: Tags: Adult Urology Source Type: research